Alamar Biosciences, Inc.
ALMR
$20.76
$0.562.75%
NASDAQ
| 03/31/2026 | |||||
|---|---|---|---|---|---|
| Revenue | 98.88% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 98.88% | ||||
| Cost of Revenue | 72.75% | ||||
| Gross Profit | 126.28% | ||||
| SG&A Expenses | 107.64% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 77.33% | ||||
| Operating Income | -44.36% | ||||
| Income Before Tax | -172.37% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -178.43% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -178.43% | ||||
| EBIT | -44.36% | ||||
| EBITDA | -45.86% | ||||
| EPS Basic | -155.68% | ||||
| Normalized Basic EPS | -47.08% | ||||
| EPS Diluted | -155.68% | ||||
| Normalized Diluted EPS | -47.08% | ||||
| Average Basic Shares Outstanding | 8.89% | ||||
| Average Diluted Shares Outstanding | 8.89% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||